At Arrowhead’s 2011 Personalized Medicine Partnerships Conference, we will highlight key issues in forming partnerships and engage the best speakers to share their experiences with you. These key issues include:
- what pharmaceutical and diagnostic companies are looking for in a partner
- partnering challenges that arise within the realm of contractual negotiations, IP protection, regulatory affairs and commercialization
- benefits of partnerships, including more effective, efficient and safer clinical trials
- how and when to start a relationship, ie. discovery, clinical, post-commercialization?
- the risks of partnering
You will also have multiple chances to network and meet with others in the industry during one-to-one meetings and networking breaks and receptions. There will also be an online networking tool available before the conference even begins!
Other key features of this conference include:
- PANEL DISCUSSIONS covering a variety of topics of interest to stakeholders in personalized medicine
- Presentations from companies and institutions on cutting edge of personalized medicine
- NEW CASE STUDIES on recent successes and failures in personalized medicine
- UPDATES on US and European regulatory environments and their impact on personalized medicine
- Presentations on the challanges of biomarkers development
- KEY INSIGHT from payors on current and future reimbursement of personalized medicine
- PANEL DISCUSSIONS concerning drug and companion diagnostic co-development intellectual property, deal structure, risk management and commercialization challenges
Background
Current headlines coming out of Washington suggest that personalized medicine has taken on a level of importance heretofore unseen. As federal funding for comparative effectiveness research and support for personalized medicine from the NIH seems likely, pharmaceutical companies and molecular diagnostics companies increasingly need one another to advance their clinical programs and prove the value of this new healthcare paradigm to both governments and the insurance industry.
Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects.
Studies can go well beyond the resources of a single company or laboratory; therefore, biotech and pharmaceutical companies are joining forces to better research personalized medicine and produce results for patients. However, there have been many barriers to forming successful partnerships.
Networking Opportunities
Attendees will have the opportunity to form partnerships through the following networking services:
- Online partnering software available prior to the event. Attendees can schedule one-on-one meetings prior to the conference and print out a schedule of meeting times during the conference.
- One-to-one partnering meetings. Attendees can set up meetings during the event in order to form business relationships and find potential partners.
- Networking breaks. These will give attendees the chance to meet those with whom they many not have set up meetings.
- End of the day receptions. Again, this will give attendees the chance to mingle with other professionals after a day full of speakers, meetings, and thought-provoking topics.
Who Will Attendees Meet?
- Biotech companies
- Pharmaceutical companies
- Diagnostic companies
- Financial groups
- Other industry-related service companies